太安堂(002433.SZ):宏興集團擬以1.02億元轉讓宏裕貿易100%股權予融泰貿易及陳錫平
格隆匯8月6日丨太安堂(002433.SZ)公佈,公司於2021年8月6日召開了第五屆董事會第二十六次會議,審議通過了《關於轉讓控股孫公司股權的議案》,為盤活公司控股子公司廣東宏興集團股份有限公司(“宏興集團”)資產,同意公司控股子公司宏興集團轉讓其全資持有的潮州市宏裕貿易有限公司(“宏裕貿易”)的100%股權,其中70%股權以7140萬元的價格轉讓給潮州市融泰建材貿易有限公司(“融泰貿易”),30%股權以3060萬元的價格轉讓給陳錫平。
此次交易系盤活公司資產,預計將增加上市公司合併財務報表當期利潤總額約3500萬元至3800萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.